Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Radiation Exposure from Fluoroscopy during Hip Arthroscopy.

PMID: 31763460
Journal: Surgery journal (New York, N.Y.)
Year: 2019
Reference: Surg J (N Y). 2019 Nov 21;5(4):e184-e187. doi: 10.1055/s-0039-3400278. eCollection 2019 Oct.
Impact factor: 0
Publication type: Paper in international publication
Authors: Seijas, Roberto, Catala, Jordi, Cepas, Miguel Angel, Sallent, Andrea, Ares, Oscar, Barastegui, David et al.
DOI: 10.1055/s-0039-3400278

Radical Hysterectomy: Efficacy and Safety in the Dawn of Minimally Invasive Techniques.

PMID: 29908339
Journal: Journal of Minimally Invasive Gynecology
Year: 2019
Reference: J Minim Invasive Gynecol. 2019 Mar - Apr;26(3):492-500. doi: 10.1016/j.jmig.2018.06.007. Epub 2018 Jun 13.
Impact factor: 2.414
Publication type: Paper in international publication
Authors: Gil-Moreno, Antonio, Carbonell-Socias, Melchor, Salicru, Sabina, Centeno-Mediavilla, Cristina, Franco-Camps, Silvia, Colas, Eva, Oaknin, Ana, Perez-Benavente, Assumpcio, Diaz-Feijoo, Berta et al.
DOI: 10.1016/j.jmig.2018.06.007

Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.

PMID: 31035085
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2019
Reference: Eur J Cancer. 2019 Jun;114:36-46. doi: 10.1016/j.ejca.2019.03.018. Epub 2019 Apr 28.
Impact factor: 6.68
Publication type: Paper in international publication
Authors: de Rojas, Teresa, Clementel, Enrico, Giralt, Jordi, Cruz, Ofelia, Boterberg, Tom, Kortmann, Rolf-Dieter, Gaze, Mark N, Moreno, Lucas, Janssens, Geert O et al.
DOI: 10.1016/j.ejca.2019.03.018

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.

PMID: 30612558
Journal: BMC CANCER
Year: 2019
Reference: BMC Cancer. 2019 Jan 7;19(1):12. doi: 10.1186/s12885-018-5203-y.
Impact factor: 2.933
Publication type: Paper in international publication
Authors: Heidenreich, Axel, Gillessen, Silke, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M, Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica et al.
DOI: 10.1186/s12885-018-5203-y

Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.

PMID: 31301962
Journal: LANCET ONCOLOGY
Year: 2019
Reference: Lancet Oncol. 2019 Aug;20(8):1109-1123. doi: 10.1016/S1470-2045(19)30458-9. Epub 2019 Jul 10.
Impact factor: 35.386
Publication type: Paper in international publication
Authors: Arkenau, Hendrik-Tobias, Santana-Davila, Rafael, Calvo, Emiliano, Paz-Ares, Luis, Cassier, Philippe A, Bendell, Johanna, Penel, Nicolas, Krebs, Matthew G, Martin-Liberal, Juan, Isambert, Nicolas et al.
DOI: 10.1016/S1470-2045(19)30458-9

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.

PMID: 30718072
Journal: LANCET ONCOLOGY
Year: 2019
Reference: Lancet Oncol. 2019 Mar;20(3):420-435. doi: 10.1016/S1470-2045(18)30791-5. Epub 2019 Feb 1.
Impact factor: 35.386
Publication type: Paper in international publication
Authors: Prausova, Jana, Van Cutsem, Eric, Ilson, David H, Alsina, Maria, Chau, Ian, Lacy, Jill, Ducreux, Michel, Mendez, Guillermo Ariel, Alavez, Alejandro Molina, Takahari, Daisuke et al.
DOI: 10.1016/S1470-2045(18)30791-5

Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.

PMID: 30654297
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2019
Reference: Eur J Cancer. 2019 Feb;108:120-128. doi: 10.1016/j.ejca.2018.11.028. Epub 2019 Jan 14.
Impact factor: 6.68
Publication type: Paper in international publication
Authors: Paz-Ares, Luis, Levy, Benjamin P, Giaccone, Giuseppe, Besse, Benjamin, Felip, Enriqueta, Garassino, Marina Chiara, Domine Gomez, Manuel, Garrido, Pilar, Piperdi, Bilal, Ponce-Aix, Santiago et al.
DOI: 10.1016/j.ejca.2018.11.028

Randomized, Double-blind, Placebo-controlled, Multicenter Study of Siltuximab in High-risk Smoldering Multiple Myeloma.

PMID: 30890552
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Jul 1;25(13):3772-3775. doi: 10.1158/1078-0432.CCR-18-3470. Epub 2019 Mar 19.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Goldschmidt, Hartmut, Brighton, Timothy A, Khot, Amit, Harrison, Simon J, Ghez, David, Weiss, Brendan M, Kirsch, Andreas, Magen, Hila, Gironella, Mercedes, Oriol, Albert et al.
DOI: 10.1158/1078-0432.CCR-18-3470

Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND).

PMID: 32085197
Journal: ANNALS OF ONCOLOGY
Year: 2019
Reference: Ann Oncol. 2019 Jul;30 Suppl 4:iv52. doi: 10.1093/annonc/mdz155.190. Epub 2019 Dec 4.
Impact factor: 14.196
Publication type: Letter or abstract
Authors: Maurel, J, Taberner, M, Rodriguez-Salas, N, Aparicio, J, Virgili, A, Capdevila, J, Munoz Boza, F, Alvarez, R, Bosch, C, Camara, J et al.
DOI: 10.1093/annonc/mdz155.190

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.

PMID: 30975923
Journal: ONCOLOGIST
Year: 2019
Reference: Oncologist. 2019 Aug;24(8):1095-1102. doi: 10.1634/theoncologist.2018-0695. Epub 2019 Apr 11.
Impact factor: 5.252
Publication type: Paper in international publication
Authors: Lopez-Chavez, Ariel, Doebele, Robert C, Modiano, Manuel R, Jackman, David Michael, Baggstrom, Maria Quintos, Atmaca, Akin, Felip, Enriqueta, Provencio, Mariano, Cobo, Manuel, Adiwijaya, Bambang et al.
DOI: 10.1634/theoncologist.2018-0695

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

PMID: 30901302
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 May 20;37(15):1285-1295. doi: 10.1200/JCO.18.02403. Epub 2019 Mar 22.
Impact factor: 28.245
Publication type: Paper in international publication
Authors: Turgut, Mehmet, Jurczak, Wojciech, Cheung, Matthew C, Gurion, Ronit, Yeh, Su-Peng, Lopez-Hernandez, Andres, Duhrsen, Ulrich, Thieblemont, Catherine, Chiattone, Carlos Sergio, Balasubramanian, Sriram et al.
DOI: 10.1200/JCO.18.02403

Randomized Placebo-controlled Clinical Trial on Efficacy and Safety of Topical 10% Potassium Hydroxide for Molluscum Contagiosum Treatment in Children.

PMID: 30668179
Journal: JOURNAL OF DERMATOLOGICAL TREATMENT
Year: 2019
Reference: J Dermatolog Treat. 2019 Dec;30(8):750-756. doi: 10.1080/09546634.2019.1573305. Epub 2019 Feb 3.
Impact factor: 2.112
Publication type: Paper in international publication
Authors: Vlacho, Bogdan, Morros, Rosa, Pera, Helena, Diez, Olga, Marsal, Josep R, Teixido, Concepcio, Giner-Soriano, Maria et al.
DOI: 10.1080/09546634.2019.1573305

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.

PMID: 31434968
Journal: Scientific Reports
Year: 2019
Reference: Sci Rep. 2019 Aug 21;9(1):12163. doi: 10.1038/s41598-019-48592-5.
Impact factor: 4.011
Publication type: Paper in international publication
Authors: Bellon, J M, Bermejo, J, Hontanon, V, Arribas, J R, Montes, M L, Bernardino, I, Pascual, J F, Zamora, F, Pena, J M, Arnalich, F et al.
DOI: 10.1038/s41598-019-48592-5

Rapid Influenza Testing in Infants and Children Younger than 6 Years in Primary Care: Impact on Antibiotic Treatment and Use of Health Services.

PMID: 31310597
Journal: PEDIATRIC INFECTIOUS DISEASE JOURNAL
Year: 2019
Reference: Pediatr Infect Dis J. 2019 Aug;38(8):e187-e189. doi: 10.1097/INF.0000000000002287.
Impact factor: 2.317
Publication type: Paper in international publication
Authors: van Esso, Diego L, Valente, Ana Marta, Vila, Monica, de Quixano, Marta, Rodrigo, Carlos, Anton, Andres, Pumarola, Tomas, Casanovas, Josep M et al.
DOI: 10.1097/INF.0000000000002287

Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals.

PMID: 31467675
Journal: Therapeutic advances in infectious disease
Year: 2019
Reference: Ther Adv Infect Dis. 2019 Aug 21;6:2049936119868028. doi: 10.1177/2049936119868028. eCollection 2019 Jan-Dec.
Impact factor: 0
Publication type: Paper in international publication
Authors: Rojo, S, Roc, Lourdes, de Mendoza, Carmen, Fernandez-Alonso, Miriam, Reina, Gabriel, Soriano, Vicente, Rodriguez, C, Vera, M, Del Romero, J, Marcaida, G et al.
DOI: 10.1177/2049936119868028

RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma.

PMID: 30969136
Journal: Future Oncology
Year: 2019
Reference: Future Oncol. 2019 Jun;15(16):1811-1822. doi: 10.2217/fon-2019-0097. Epub 2019 Apr 10.
Impact factor: 2.279
Publication type: Paper in international publication
Authors: Zhu, Andrew X, Song, James, Hou, Jeannie, Qin, Shukui, Finn, Richard S, Kudo, Masatoshi, Meyer, Tim, Vogel, Arndt, Ducreux, Michel, Macarulla, Teresa Mercade et al.
DOI: 10.2217/fon-2019-0097

Rationale and design of the HIP fracture Accelerated surgical TreaTment And Care tracK (HIP ATTACK) Trial: a protocol for an international randomised controlled trial evaluating early surgery for hip fracture patients.

PMID: 31048449
Journal: BMJ Open
Year: 2019
Reference: BMJ Open. 2019 May 1;9(4):e028537. doi: 10.1136/bmjopen-2018-028537.
Impact factor: 2.376
Publication type: Paper in international publication
Authors: Umer, Masood, Borges, Flavia K, Bhandari, Mohit, Patel, Ameen, Avram, Victoria, Guerra-Farfan, Ernesto, Sigamani, Alben, Shanthanna, Harsha, Moppett, Iain, Vincent, Jessica et al.
DOI: 10.1136/bmjopen-2018-028537

Rationale and Study Design for an Individualized Perioperative Open Lung Ventilatory Strategy in Patients on One-Lung Ventilation (iPROVE-OLV).

PMID: 30928294
Journal: JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
Year: 2019
Reference: J Cardiothorac Vasc Anesth. 2019 Sep;33(9):2492-2502. doi: 10.1053/j.jvca.2019.01.056. Epub 2019 Feb 8.
Impact factor:
Publication type: Paper in international publication
Authors: Aguirre-Puig, Pilar; Belda, Javier; Bellas, Soledad; Cabrera, Maria; Carraminana, Albert; Celestino, Catarina; Cervantes, Oriol; Cinnella, Gilda; Coves, Silvia; Delphy, Dalia et al.
DOI: 10.1053/j.jvca.2019.01.056

RB1 Heterogeneity in Advanced Metastatic Castration Resistant Prostate Cancer.

PMID: 30257982
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Jan 15;25(2):687-697. doi: 10.1158/1078-0432.CCR-18-2068. Epub 2018 Sep 26.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Casiraghi, Nicola, Nava Rodrigues, Daniel, Miranda, Susana, Rescigno, Pasquale, Figueiredo, Ines, Riisnaes, Ruth, Carreira, Suzanne, Sumanasuriya, Semini, Gasperini, Paola, Sharp, Adam et al.
DOI: 10.1158/1078-0432.CCR-18-2068

Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis.

PMID: 30940920
Journal: Nature Reviews Neurology
Year: 2019
Reference: Nat Rev Neurol. 2019 May;15(5):287-300. doi: 10.1038/s41582-019-0170-8.
Impact factor: 21.155
Publication type: Review in international publication
Authors: Montalban, Xavier, Rotstein, Dalia et al.
DOI: 10.1038/s41582-019-0170-8

Real life outcomes of patients aged >/=75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.

PMID: 31068052
Journal: LEUKEMIA & LYMPHOMA
Year: 2019
Reference: Leuk Lymphoma. 2019 Nov;60(11):2720-2732. doi: 10.1080/10428194.2019.1607327. Epub 2019 May 9.
Impact factor: 2.674
Publication type: Paper in international publication
Authors: Gil, Cristina, Brunet, Salut, Ramos, Fernando, Esteve, Jordi, Amigo, Mariluz, Krsnik, Isabel, Manso, Felix, Arias, Jesus, Gonzalez-Campos, Jose, Serrano, Josefina et al.
DOI: 10.1080/10428194.2019.1607327

Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.

PMID: 30316648
Journal: INTERNATIONAL JOURNAL OF CARDIOLOGY
Year: 2019
Reference: Int J Cardiol. 2019 Jan 15;275:158-164. doi: 10.1016/j.ijcard.2018.10.012. Epub 2018 Oct 5.
Impact factor: 3.471
Publication type: Paper in international publication
Authors: Del Pozo, Roberto, Blanco, Isabel, Hernandez-Gonzalez, Ignacio, Lopez-Meseguer, Manuel, Lopez-Reyes, Raquel, Lazaro-Salvador, Maria, Elias-Hernandez, Teresa, Alvarez-Vega, Pablo, Perez-Penate, Gregorio Miguel, Martinez-Menaca, Amaya et al.
DOI: 10.1016/j.ijcard.2018.10.012

Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma.

PMID: 31196680
Journal: Clinical Genitourinary Cancer
Year: 2019
Reference: Clin Genitourin Cancer. 2019 Jun;17(3):e526-e533. doi: 10.1016/j.clgc.2019.01.018.
Impact factor: 2.45
Publication type: Paper in international publication
Authors: Jonasch, Eric, Rodriguez, Cristina Suarez, Ahmad, Qasim, Hirschberg, Yulia, Procopio, Giuseppe, Bamias, Aristotelis, Schmidinger, Manuela, Hawkins, Robert, Sanchez, Angel Rodriguez, Estevez, Sergio Vazquez et al.
DOI: 10.1016/j.clgc.2019.01.018

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia.

PMID: 31102204
Journal: ADVANCES IN THERAPY
Year: 2019
Reference: Adv Ther. 2019 Jul;36(7):1786-1811. doi: 10.1007/s12325-019-00985-8. Epub 2019 May 17.
Impact factor: 3.26
Publication type: Paper in international publication
Authors: Santos, Raul D, Masana, Luis, Kolovou, Genovefa, Ariceta, Gema, Novoa, F Javier, Lund, Allan M, Bogsrud, Martin P, Araujo, Maria, Hussein, Osamah, Ibarretxe, Daiana et al.
DOI: 10.1007/s12325-019-00985-8